Abby Kennedy

Abby Kennedy has a diverse and extensive work experience in the field of clinical operations. Abby currently holds the position of Vice President of Clinical Operations at CymaBay Therapeutics since March 2021. Prior to that, they worked at Principia Biopharma as a Senior Director of Clinical Operations from April 2018 to March 2021. Abby also had a significant role in Genentech as a Senior Clinical Program Leader in gRED Clinical Operations from April 2014 to April 2018. Before that, Abby held various roles at XOMA, including Sr. Manager and Manager of Clinical Operations from December 2012 to April 2014, and from August 2011 to December 2012, respectively. In addition, Abby worked at Exelixis as a Sr. Clinical Trials Manager II from an unspecified date to September 2011, and as a Sr. Scientist from July 2001 to August 2007. Abby briefly served as the Chair at the American Chemical Society in 2011. Abby's career began as a Graduate Student at the University of Arizona from an unspecified date to 2001.

Abby Kennedy pursued their education at the University of Arizona from 1996 to 2001. During this period, they earned a Doctor of Philosophy (PhD) degree in Organic Chemistry.